… This meta-analysis revealed that elevated pretreatment platelet counts were an independent
predictor of OS and DFS/PFS/TTP in lung cancer patients. Large-scale prospective studies …

… advanced lung cancer inflammation index (ALI) is reportedly associated with patient
outcomes, we investigated whether the pretreatment ALI is prognostic in NSCLC patients treated …

… prognosis value of serum CRP in patients with combined small-cell lung cancer (C-SCLC). …
C-SCLC patients from January 2000 to March 2009 were collected. The pretreatment serum …

… has been emphasized in cancer. We investigated the impact of Onodera's prognostic
nutritional index (OPNI) on clinical outcomes in small cell lung cancer (SCLC) patients. …

… cell lung cancer (NSCLC). We conducted the current meta-analysis based on published studies
to elucidate the prognostic value of pretreatment LMR … on the role of pretreatment LMR in …

… Small-cell lung cancer (SCLC) is an aggressive disease, despite an initially favorable … of
pre-treatment FDG-PET parameters on clinical outcome in limited stage (LS) SCLC patients …

… used in another study of the patients with ovarian cancer in the literature and 300 was …
patients with NSCLC. Perhaps for this reason, there was no relationship between pretreatment …

… This study examined the association between the most important prognostic factors in
non-small cell lung carcinoma (NSCLC) and self-reported pretreatment quality of life (QoL) and …

… lines could be established from 10% of clinical specimens containing large quantities of
tumor cells. In addition, cell lines were more readily established from heavily pretreated patients …

… We studied the influence of soluble syndecan-1 on outcome in 88 small cell lung cancer (SCLC)
patients treated within the context of two randomised clinical trials with platinum-based …